Contribution: Industrial Research Assistance Program – Contributions to Firms
SOBIO PHARMACEUTIQUE CANADA INC.
$500,000.00
Development, production and marketing of new products based on ion exchange resins
FY 2016-17 · 2017-03-01
Summary
The research work consists in developing a coated tablet formula and bio-equivalent to the Canadian reference in powder form. The tablet must be stable and has olfactory-gustatory characteristics superior to that of the powder. The manufacturing process, must ensure the stability of the product in the long run.
Department
Program
Industrial Research Assistance Program – Contributions to FirmsIndustrial Research Assistance Program-Contributions to Firms (linked with high confidence)
Recipient
Location
Laval|Laval, Quebec, Canada
Recipient Type
For-profit organization
Business Number
811264589
Type
Contribution
Source
Proactive Disclosure - Grants and Contributions
Amendments
Each version of the agreement as published, oldest first, with its total as of that version. The amount above is the latest.
| Amendment | Date | Fiscal Year | Total |
|---|---|---|---|
| 2 | 2017-03-01 | 2016-17 | $500,000.00 |
| 3 | 2017-03-01 | 2016-17 | $500,000.00 |
As published
Additional Information
This agreement has been amended 1 time(s). The end date of this agreements has been modified by 91 days.
Additional Information (French)
Cet accord a été modifié 1 fois La date de fin du présent accord a été changé de 91 jours.
Agreement End Date
2019-11-01
Agreement Number
882607
Agreement Start Date
2017-03-01
Agreement Title
Development, production and marketing of new products based on ion exchange resins
Agreement Title (French)
Développement, production et commercialisation de nouveaux produits à base de résines échangeuses d'ions
Agreement Type
Contribution
Agreement Value
$500,000.00
Amendment Date
2019-08-09
Amendment Number
3
Coverage
IRAP Contributions to Firms projects stimulate wealth creation for Canada through technological innovation. | Les projets des Contributions aux entreprises stimulent la création de richesse au Canada grâce à l’innovation technologique.
Description
The research work consists in developing a coated tablet formula and bio-equivalent to the Canadian reference in powder form. The tablet must be stable and has olfactory-gustatory characteristics superior to that of the powder. The manufacturing process, must ensure the stability of the product in the long run.
Description (French)
Le travail de recherche consiste à développer une formule de comprimé enrobé et bio-équivalent à la référence Canadienne sous forme de poudre.
Le comprimé doit être stable et présente des caractéristiques olfacto-gustative supérieurs à celle de la poudre.
Le procédé de manufacture, doit assurer la stabilité du produit à long terme.
Expected Results
The purpose of IRAP Contributions to Firms is to support research, development, adoption and/or adaptation of innovative or technology-driven new or improved products, services or processes in Canada up to their commercialization
Expected Results (French)
Le PARI, par le biais des Contributions aux entreprises, vise à appuyer la recherche, le développement, l’adaptation et/ou l’adoption au Canada de produits, de services ou de processus novateurs ou axés sur des technologies nouvelles ou améliorées, et ce jusqu’à leur commercialisation
Federal Riding
Vimy
Federal Riding (French)
Vimy
Federal Riding Number
24078
NAICS Code
541710
Organization Code
nrc-cnrc
Organization
National Research Council Canada | Conseil national de recherches Canada
Program Name
Industrial Research Assistance Program – Contributions to Firms
Program Name (French)
Programme d’aide à la recherche industrielle – Contributions aux entreprises
Program Purpose
The purpose of IRAP Contributions to Firms is to support research, development, adoption and/or adaptation of innovative or technology-driven new or improved products, services or processes in Canada up to their commercialization
Program Purpose (French)
Le PARI, par le biais des Contributions aux entreprises, vise à appuyer la recherche, le développement, l’adaptation et/ou l’adoption au Canada de produits, de services ou de processus novateurs ou axés sur des technologies nouvelles ou améliorées, et ce jusqu’à leur commercialisation
Recipient Business Number
811264589
Recipient City
Laval|Laval
Recipient Country
CA
Recipient Legal Name
SOBIO PHARMACEUTIQUE CANADA INC.
Recipient Postal Code
H7V 4B4
Recipient Province or Territory
QC
Recipient Type
F
Reference Number
172-2018-2019-Q4-882607
